News
- Author:
- Marcia Frellick
Publish date: November 6, 2023
A large Veterans Affairs study finds that Black men with a prebiopsy PSA level of 4.0 ng/mL had the same risk of prostate cancer as White men with ...
News
- Author:
- Marcia Frellick
Publish date: October 27, 2023
Researchers find it also may help prevent anemia in middle-aged and older men.
News
- Author:
- Marcia Frellick
Publish date: October 20, 2023
“Clinicians should be aware of the significantly higher incidence of [lower urinary tract infection] complications with COVID-19 in this patient gr...
News
- Author:
- Marcia Frellick
Publish date: October 19, 2023
With this approval, bimekizumab becomes the only interleukin (IL)-17A and IL-17F inhibitor approved for the treatment of these patients.
News
- Author:
- Marcia Frellick
Publish date: October 17, 2023
Researchers find differences in gene expression before pregnancy that could help women with rheumatoid arthritis choose to stop or continue medicat...
News
- Author:
- Marcia Frellick
Publish date: October 9, 2023
Large study also helps answer questions on duration of effectiveness and the potential “blunting” effect in infants.
News
- Author:
- Marcia Frellick
Publish date: October 2, 2023
The default should be to include children in conversations about their illness in a developmentally appropriate way, AAP says.
News
- Author:
- Marcia Frellick
Publish date: September 22, 2023
A small randomized, controlled study finds a significant reduction in hallmark long COVID symptoms, but there are important unanswered questions.
News
- Author:
- Marcia Frellick
Publish date: September 13, 2023
MIST, compared with sham treatment, did not reduce death or neurodevelopmental disability, but infants who received MIST had lower rates of poor re...
News
- Author:
- Marcia Frellick
Publish date: September 12, 2023
Researchers identified a blood-level reference range linked with 71% lower odds of active lupus.
News
- Author:
- Marcia Frellick
Publish date: September 5, 2023
The agency is making the case that sepsis needs more funding in hospitals that either don’t have the programs or aren’t supporting them with dedica...
News
- Author:
- Marcia Frellick
Publish date: August 31, 2023
Many patients “don’t hit their optimal results at 3 months, 6 months, even the year mark. With continued use, many can see continued benefit,” Davi...
News
- Author:
- Marcia Frellick
Publish date: August 31, 2023
The understanding that human papillomavirus causes oropharyngeal squamous cell carcinoma (OPSCC) has been linked with increased likelihood of adult...
News
- Author:
- Marcia Frellick
Publish date: August 28, 2023
Guidance updates developmental milestones and screening recommendations and changes terminology to eliminate references such as “failed” and “impai...
News
- Author:
- Marcia Frellick
Publish date: August 24, 2023
Monoclonal antibodies are often used for treatment rather than prevention.
